Fighting diseases of global impact
Our unique research expertise makes us the only institute of its kind in Australia and only one of a handful in the world. We seek to collaborate with leading scientists around the world to build a critical mass around this multidisciplinary research. Global collaboration is essential to achieving our vision to bring forward novel drugs and vaccines to the community.
What is glycomics?
Glycomics is the study of glycomes (the entire complement of sugars, whether free or present in more complex molecules of an organism), including genetic, physiologic, pathologic, and other aspects. The term glycomics comes from the chemical prefix for sweetness or a sugar, "glyco-", and follows the naming convention established by genomics (which deals with genes) and proteomics (which deals with proteins).
A major research theme is discovering the role that carbohydrates play in disease and with that knowledge to develop new drugs and vaccines which will interfere with the biological process of disease. We provide a multidisciplinary approach to research and education, spanning medicinal and computational chemistry, various biological and physical sciences. This approach presents an exciting platform for the control of a wide-range of medical conditions such as infectious disease, cancer and other disorders.
Industry & Investors
We aim to work in partnership with businesses that are keen to take a proactive role in internationally significant public health issues leading to healthier, longer and better lives for Australians.
Study with us
We offer candidates who want to make a difference and help us make our next discovery various projects, work experience and scholarship opportunities. There are also postgraduate study opportunities in glycomics.
November 19, 2018
Hope for new blood test to detect early stage ovarian cancer
Potential to improve early detection of disease possible with new test.
November 19, 2018
Researchers a step closer to understanding how deadly bird flu virus takes hold in humans
How highly pathogenic influenza viruses such as deadly bird flu infect humans is being unravelled.
October 18, 2018
Human trial success signals next stage of malaria vaccine development
Initial success in human clinical trials has given hope for the next stage in the development of a new malaria vaccine.
Development of a new class of antibiotics gives hope for treating multi-drug resistant bacteria
New type of antibiotic could limit multidrug resistance by targeting and disrupting key elements in bacterial cells.